Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Faivre

Showing results (221-230 of 361) with videos related to

Pageof 37
Sort By:
Developmental Cell|August 9, 2011
Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine developmentFlorence Y Lee, Emily J Faivre, Miyuki Suzawa, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1995
[Treatment of cancer of the rectum. Practical survey based on 7 French departments in 1990]J Maurel, P Grosclaude, D Pottier, et al.
Molecular and Cellular Biology|October 8, 2008
Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1)Lioudmila A Campbell, Emily J Faivre, Matthew D Show, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2011
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002J Faivre, A Trama, R De Angelis, et al.
Pediatrie|January 1, 1989
[Neonatal Proteus mirabilis septicemia and cerebral abscess. Value of the assay of antibiotics in the puncture fluid]I Casadevall, P Betremieux, P Y Donnio, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Digestive cancers in France. Geographic distribution and estimation of national incidence]J Faivre, P Grosclaude, G Launoy, et al.
Gastroenterologie Clinique Et Biologique|December 11, 1999
[Estimation of the incidence of digestive tract cancers by region]A M Benhamiche, M Colonna, I Aptel, et al.
Bulletin Du Cancer|January 1, 1989
[Acceptability of the Hemoccult test in general medical practice. Results of a pilot study]F Archambault, G Durand, J Faivre, et al.
Cell Death & Disease|September 21, 2013
The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cellsF Guerrieri, S Piconese, C Lacoste, et al.
Gastroenterologie Clinique Et Biologique|August 4, 2009
[Current management and prognosis of intrahepatic cholangiocarcinoma in France]F Borie, H Niampa, A-M Bouvier, et al.
Pageof 37

Showing results (221-230 of 361) with videos related to

Sort By:
Pageof 37
Developmental Cell|August 9, 2011
Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine developmentFlorence Y Lee, Emily J Faivre, Miyuki Suzawa, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1995
[Treatment of cancer of the rectum. Practical survey based on 7 French departments in 1990]J Maurel, P Grosclaude, D Pottier, et al.
Molecular and Cellular Biology|October 8, 2008
Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1)Lioudmila A Campbell, Emily J Faivre, Matthew D Show, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2011
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002J Faivre, A Trama, R De Angelis, et al.
Pediatrie|January 1, 1989
[Neonatal Proteus mirabilis septicemia and cerebral abscess. Value of the assay of antibiotics in the puncture fluid]I Casadevall, P Betremieux, P Y Donnio, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Digestive cancers in France. Geographic distribution and estimation of national incidence]J Faivre, P Grosclaude, G Launoy, et al.
Gastroenterologie Clinique Et Biologique|December 11, 1999
[Estimation of the incidence of digestive tract cancers by region]A M Benhamiche, M Colonna, I Aptel, et al.
Bulletin Du Cancer|January 1, 1989
[Acceptability of the Hemoccult test in general medical practice. Results of a pilot study]F Archambault, G Durand, J Faivre, et al.
Cell Death & Disease|September 21, 2013
The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cellsF Guerrieri, S Piconese, C Lacoste, et al.
Gastroenterologie Clinique Et Biologique|August 4, 2009
[Current management and prognosis of intrahepatic cholangiocarcinoma in France]F Borie, H Niampa, A-M Bouvier, et al.
Pageof 37